Arjan Diepstra
dr.
As a hematopathologist, I work on diagnostics of all types of hematological malignancies using a comprehensive panel of different techniques. Moreover, my main research interest involves Hodgkin lymphoma, with a strong focus on interactions between tumor cells and the microenvironment. In addition, I also have a long standing interest in genetic susceptibility. My areas of expertise are: immunology, tumor cell biology, genetic association studies and molecular diagnostics in pathology. I actively participate in international (EORTC) and national (HOVON) clinical trials.
Latest publications
(215)
Activities
(38)
Press/Media
(6)
Prizes
(4)
Datasets
(1)
Supervised work
(11)
Renal Endothelial Cytotoxicity Assay to Diagnose and Monitor Renal Transplant Recipients for Anti-Endothelial Antibodies
Published in: Frontiers in Immunology
Access to document
10.3389/fimmu.2022.845187
document
Tissue-specific nonhuman leukocyte antigen (HLA) antigens can play crucial roles in allograft immunity and have been shown to trigger humoral responses leading to rejection of HLA-matched kidney allografts. Interest in the role of endothelial-specific antigens has grown over the past years, and several case reports have been described in which antibodies reacting with endothelial cells (ECs) are associated with rejection. Such antibodies escape the detection in conventional crossmatch tests as they do not react with lymphocytes. However, due to the heterogeneity of endothelial cells from different vascular beds,...
COMBAT Consortium, Rosa G M Lammerts, Jacob van den Born, Magdalena Huberts-Kregel, Antonio W Gomes-Neto, Mohammed R Daha, Bouke G Hepkema, Jan-Stephan Sanders, Robert A Pol, Arjan Diepstra, Stefan P Berger
Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in Cancer
Published in: Cancers
Access to document
10.3390/cancers14102397
document
Simple Summary Our work establishes that amplification of 4EBP1, as a part of Chr. 8p11, creates a synthetic dependency on FGFR1 signaling in cancer. 4EBP1 is phosphorylated by FGFR1 and PI3K signaling, and accordingly cancer with 4EBP1-FGFR1 amplification is more sensitive to FGFR1 and PI3K inhibition due to inhibition of 4EBP1 phosphorylation. Moreover, we characterize the translational targets of 4EBP1 and identify that 4EBP1 specifically regulates the translation of genes involved in insulin signaling, glucose metabolism, and the inositol pathway that plays a role in cancer progression. The...
Prathibha Mohan, Joyce Pasion, Giovanni Ciriello, Nathalie Lailler, Elisa de Stanchina, Agnes Viale, Anke van den Berg, Arjan Diepstra, Hans-Guido Wendel, Viraj R. Sanghvi, Kamini Singh
Bone marrow necrosis as complication of treatment with all-trans retinoic acid and arsenic trioxide: case report and implications for treatment
Published in: Annals of Hematology
Access to document
10.1007/s00277-021-04720-8
document
Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney
Published in: Frontiers in Immunology
Access to document
10.3389/fimmu.2022.845301
document
Background: The role of the complement system in antibody-mediated rejection (ABMR) is insufficiently understood. We aimed to investigate the role of local and systemic complement activation in active (aABMR). We quantified complement activation markers, C3, C3d, and C5b-9 in plasma of aABMR, and acute T-cell mediated rejection (aTCMR), and non-rejection kidney transplant recipients. Intra-renal complement markers were analyzed as C4d, C3d, C5b-9, and CD59 deposition. We examined in vitro complement activation and CD59 expression on renal endothelial cells upon incubation with human leukocyte antigen antibodies. Methods: We included...
COMBAT Consortium, Gesa Tiller, Rosa G. M. Lammerts, Jessy J. Karijosemito, Firas F. Alkaff, Arjan Diepstra, Robert A. Pol, Anita H. Meter-Arkema, Marc. A. Seelen, Marius C. van den Heuvel, Bouke G. Hepkema, Mohamed R. Daha, Jacob van den Born, Stefan P. Berger